MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
Aspira Women's Health Operating Cash Flow 2011-2026 | AWH
Annual Operating Cash Flow Aspira Women's Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -32.2 M | -27.4 M | -14.7 M | -13 M | -9.37 M | -8.13 M | - | - | - | - | -10.4 M | -15.6 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -8.13 M | -32.2 M | -16.3 M |
Quarterly Operating Cash Flow Aspira Women's Health
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -3.1 M | - | - | - | -4.43 M | - | 3.32 M | 3.42 M | -5.71 M | - | -25.1 M | -16.5 M | -10.2 M | - | -19.7 M | -11.7 M | -5.26 M | - | -9.98 M | -6.91 M | -3.5 M | - | -10.1 M | -6.65 M | -3.11 M | - | -7.07 M | -4.78 M | -2.36 M | - | -5.98 M | -4.19 M | -2.42 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2.17 M | - | - | -5.96 M | -2.62 M | - | -10.8 M | -6.77 M | -2.85 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.42 M | -25.1 M | -6.66 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
884 K | $ 22.91 | 3.62 % | $ 99.4 M |  Israel |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
-478 M | $ 22.79 | 1.92 % | $ 246 M |  China |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
BioNano Genomics
BNGO
|
-68.9 M | $ 1.61 | 0.89 % | $ 2.05 M | USA |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 40.16 | -1.12 % | $ 1.12 B | USA |
 |
Co-Diagnostics
CODX
|
-22.1 M | $ 5.76 | -4.48 % | $ 169 M | USA |
 |
DarioHealth Corp.
DRIO
|
-30.4 M | $ 12.5 | 3.05 % | $ 355 M | Israel |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 28.01 | - | $ 847 M | USA |
 |
Danaher Corporation
DHR
|
6.69 B | $ 235.87 | 0.12 % | $ 172 B | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | China |
 |
DexCom
DXCM
|
748 M | $ 68.01 | -2.98 % | $ 26.3 B | USA |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
211 M | $ 101.7 | 0.07 % | $ 18.8 B | USA |
 |
CareDx, Inc
CDNA
|
-18.4 M | $ 18.13 | -4.07 % | $ 975 M | USA |
 |
Celcuity
CELC
|
-83.5 M | $ 108.23 | -0.87 % | $ 4.27 B | USA |
 |
Anixa Biosciences
ANIX
|
-7.34 M | $ 3.32 | 1.22 % | $ 106 K | USA |
 |
Guardant Health
GH
|
-240 M | $ 109.17 | -0.69 % | $ 13.4 B | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
2.72 B | $ 241.42 | -1.17 % | $ 43.8 B | USA |
 |
Illumina
ILMN
|
837 M | $ 146.4 | -2.49 % | $ 23.3 B | USA |
 |
Charles River Laboratories International
CRL
|
735 M | $ 213.74 | -1.62 % | $ 11 B | USA |
 |
Mettler-Toledo International
MTD
|
968 M | $ 1 478.71 | 0.58 % | $ 31.4 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-8.7 M | $ 6.64 | 0.15 % | $ 602 M | USA |
 |
National Research Corporation
NRC
|
38.1 M | $ 19.3 | 2.12 % | $ 474 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.33 B | $ 178.17 | -0.02 % | $ 19.8 B | USA |
|
Biodesix
BDSX
|
-48.6 M | $ 5.88 | -1.34 % | $ 762 M | USA |
 |
Natera
NTRA
|
-432 M | $ 245.0 | -3.7 % | $ 24.1 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.59 B | $ 255.84 | 0.86 % | $ 21.5 B | USA |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
OPKO Health
OPK
|
-183 M | $ 1.35 | -0.44 % | $ 937 M | USA |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 188.64 | -7.04 % | $ 15.6 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
929 M | $ 697.49 | -2.39 % | $ 57.5 B | USA |
 |
Lantheus Holdings
LNTH
|
545 M | $ 69.3 | -0.11 % | $ 4.8 B | USA |
 |
Agilent Technologies
A
|
1.48 B | $ 147.05 | -0.5 % | $ 44.7 B | USA |
 |
Biomerica
BMRA
|
-3.84 M | $ 2.7 | -2.87 % | $ 6.2 M | USA |
 |
Bioventus
BVS
|
15.3 M | $ 7.79 | 2.31 % | $ 488 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M | Israel |